BRAF and central nervous system cancer: The high-grade MAPK-pathway-induced gliomas are not considered as a real category in the 2021 WHO classification, but they clearly overlap with the previously described grade 3 PXA or GGL and are mostly enriched in BRAF p.V600E mutated forms [2,22].